<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03133481</url>
  </required_header>
  <id_info>
    <org_study_id>F140917004</org_study_id>
    <nct_id>NCT03133481</nct_id>
  </id_info>
  <brief_title>Adductor Canal Block Versus Femoral Nerve Block for Total Knee Arthroplasty</brief_title>
  <official_title>Adductor Canal Block Versus Femoral Nerve Block for Total Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Alabama at Birmingham</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
  </oversight_info>
  <brief_summary>
    <textblock>
      Peripheral nerve blocks catheters of the femoral nerve have long been used for perioperative
      analgesia in total knee arthroplasty (TKA). These blocks provide effective analgesia and
      patient satisfaction for surgical pain relief. However, one of the main drawbacks to the
      femoral nerve block (FNB) is a denser motor block of the quadriceps muscle that can delay
      aggressive physical therapy and subsequent recovery from surgery. (1) Recently, there has
      been increasing interest in performing adductor canal blocks (ACB) with the aim of less motor
      blockade while providing commensurate analgesia compared to the FNB. (1,2) Current
      investigative reports have provided only preliminary data, and there is potential to change
      the standard of care for TKA as more data mounts in favor of ACBs. The goal of this study is
      to verify the analgesic equivalence of the two blocks, compare patient satisfaction, surgeon
      satisfaction, and physical therapy grading between the two blocks. Potentially, this would
      change the standard of care for TKA patients at this institution.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The specific objectives of this study are to determine the effectiveness of ACB for analgesia
      compared to FNB as determined by patient reported VAS scores. Determine the effectiveness of
      ACB for analgesia compared to FNB as determined by opioid usage. Determine the effectiveness
      of ACB in physical therapy as determined by early ambulation distance. Determine the surgeon
      satisfaction via survey, and determine if there is any difference in time to discharge
      between the two blocks.

      Participants in the investigational group will received an adductor canal nerve catheter
      prior to TKA surgery. Participants in the control group will receive a femoral nerve catheter
      prior to TKA surgery. After surgery, the patient will be seen in the recovery room to bolus
      the catheters and start continuous infusions of ropivacaine.

      The primary endpoints include, Pain Scores (VAS) at immediate post op, 24 hours, and 48
      hours, including highest, opioid consumption at 24 hours and 48 hours pain score at any given
      time post operatively, physical therapist assessment of patient participation 0-100, distance
      ambulated at 24 to 48 hours, patient satisfaction, surgeon satisfaction, and hours to
      discharge.

      Participants will be recruited, identified, and interviewed by either the study Principal
      Investigator or one of the co-investigators. The interviewing investigator will confirm
      eligibility and the absence of any exclusionary criteria. Details of the study (including
      risks) will be explained to prospective participants to their satisfaction and consent forms
      will then be signed.

      Randomization: Upon enrollment into the study, participants will be randomized 1:1 to either
      the investigational group (adductor canal nerve catheter) or the control group (femoral nerve
      catheter). Randomization will be performed using a random number generator Participants in
      this study will be randomized into two interventional groups. The participant in the
      &quot;adductor canal nerve catheter&quot; investigational group will receive an adductor canal block
      catheter placed under direct ultrasound guidance. The participants in the &quot;femoral nerve
      catheter&quot; control group will receive a femoral nerve clock catheter placed under direct
      ultrasound guidance with a stimulating needle. Investigational group participants in the
      adductor canal block arm will receive an adductor canal block catheter placed under direct
      ultrasound guidance as follows. Patients will be placed supine with their block limb
      supinated about 20 degrees to facilitate access to the anteromedial thigh. Standard
      noninvasive monitors will be applied, and oxygen administered via nasal canula. Parenteral
      midazolam and fentanyl will be titrated to patient comfort.

      Standard skin sterilization, prepping, and draping will be applied to the area. Under
      ultrasound guidance the needle will be advanced into the adductor canal. After negative
      aspiration, a bolus of 20 ml 0.5% Ropivacaine will be injected under direct visualization in
      5 mL aliquots ensuring proper placement of the needle tip. The catheter will be advanced in
      this position at least 2 cm and not more than 5 cm and secured to the skin with tegaderm.
      Patients will be evaluated immediately post-operatively in the PACU (Post anesthesia care
      unit) to determine VAS score from 0-10.

      Patients will be given a standard pain regimen while in the hospital. 24 hour opioid
      consumption will be calculated. Patients will be evaluated 24 and 48 hours post operatively
      for VAS score, duration of sensory and motor block, and patient satisfaction from 0-10. The
      catheter will be removed on post operative day 2. Patient will be followed up until nerve
      block resolved. Physical therapists in the hospital will be surveyed with a standard
      questionnaire regarding the patients ability to participate in physical therapy sessions on a
      scale of 0-10. Ambulation distance at 24 and 48 hours will be recorded per their notes. The
      surgeons performing the procedures will be surveyed in a general sense regarding their
      impression of patient recovery with this block. The hours to discharge will be calculated.

      Control group participants in the femoral nerve block arm will receive a femoral nerve block
      catheter placed under direct ultrasound guidance with the stimulating needle as follows.
      Patients will be placed supine with their block limb exposed to facilitate access to the
      anterior inguinal area. Standard noninvasive monitors will be applied, and oxygen
      administered via nasal canula. Parenteral midazolam and fentanyl will be titrated to patient
      comfort. Standard skin sterilization, prepping, and draping will be applied to the area.
      Under ultrasound guidance the needle will be advanced to the femoral nerve. After negative
      aspiration, a bolus of 20 ml 0.5% Ropivacaine will be injected under direct visualization in
      5 mL aliquots ensuring proper placement of the needle tip. The catheter will be advanced in
      this position at least 2 cm and not more than 5 cm and secured to the skin with tegaderm.
      Patients will be evaluated immediately post-operatively in the PACU (Post anesthesia care
      unit) to determine VAS score from 0-10.

      Physical therapist and physicians will be asked to complete a short survey after their
      patient has enrolled in the study. A Waiver of Informed Consent is requested for their
      participation.

      Patients will be given a standard pain regimen while in the hospital. 24 hour opioid
      consumption will be calculated. Patients will be evaluated 24 and 48 hours post operatively
      for VAS score, duration of sensory and motor block, and patient satisfaction from 0-10. The
      catheter will be removed on post operative day 2. Patient will be followed up until nerve
      block resolved. Physical therapists in the hospital will be surveyed with a standard
      questionnaire regarding the patients ability to participate in physical therapy sessions on a
      scale of 0-100. Ambulation distance at 24 and 48 hours will be recorded per their notes. The
      surgeons performing the procedures will be surveyed in a general sense regarding their
      impression of patient recovery with this block then the hours will be calculated to the hours
      to discharge for each patient.

      All demographic and clinical variables with continuous measures will be expressed as means
      and standard deviations; categorical factors will be expressed as proportions. For non-normal
      data, the medians and inter quartile ranges will be displayed. The distribution of the
      continuous factors will be examined using the Kolmogorov-Smirnov test. For data that are
      normally distributed, the one-way ANOVA and Student's t-test will be used to compare groups
      of data. For data that are not normally distributed, the Kruskal-Wallis and Mann-Whitney
      tests will be used for comparisons. Chi-square and Fisher's exact tests will be used to
      analyze categorical data. For all comparisons, a value of p &lt; 0.05 will be considered
      statistically significant.

      Primary Outcome Analysis: Statistical analyses will be performed using SAS for Windows,
      version 9.2. Student's t-test will be used to compare post-operative pain scores for
      investigational and control subjects. Linear regression will be also be used to test the
      relationship between pain scores and regional anesthetic technique, while controlling for
      relevant clinical and demographic variables. Distance of first ambulation will be analyzed
      using Cox proportional hazards model. Student's t-test will be used to compare patient and
      surgeon satisfaction.

      Statistical Power and Sample Size Estimates: Sample size (94) was determined using a Cohen's
      d table assuming a mean pain VAS score of 8 (sd = 3) on a scale of 0-10 for control subjects.
      A sample of 94 participants (45 patients in the adductor canal block group, and 49 patients
      in the femoral nerve block group) will have approximately 80% power to detect a reduction in
      pain score of at least 50%, and approximately 99% to detect an 80% reduction in pain score.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 22, 2014</start_date>
  <completion_date type="Actual">January 2019</completion_date>
  <primary_completion_date type="Actual">October 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The first two groups will have 50 participants each (100 total) the &quot;Adductor Canal Nerve Catheter&quot; group and the &quot;Femoral Nerve Catheter,&quot; group. Participants will be randomized using block randomization. The blocks will be assigned randomly based on computer generated numbers.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Distance Ambulated at 24 Hours Post Operatively</measure>
    <time_frame>Baseline up to 24 hours after the Anesthesia Record Stop Time</time_frame>
    <description>Distance ambulated in feet from the end of surgery to 24 hours postoperatively</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean Distance Ambulated at 48 Hours Post Operatively</measure>
    <time_frame>From the Anesthesia Record Stop Time to 48 hours after the Anesthesia Record Stop Time</time_frame>
    <description>Distance ambulated in feet from the end of surgery to 48 hours postoperatively</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean Pain Scores Immediately Preoperatively</measure>
    <time_frame>baseline up to time of anesthesia record start time</time_frame>
    <description>Visual Analog Scale (VAS) score immediately preoperatively.
The Visual Analog Scale is a standard numerical pain score reported by the patient, from 0-10, where 0=no pain, and 10=worst pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Opioid Consumption as Measured by Oral Morphine Milligram Equivalents</measure>
    <time_frame>from baseline to two hours</time_frame>
    <description>Preoperatively, opioid consumption will be measured from baseline to the Anesthesia Record Start Time in Oral Morphine Equivalents</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction at 48 Hours Post Operatively</measure>
    <time_frame>Baseline up to 48 hrs</time_frame>
    <description>Patient satisfaction score, on an analog scale from 0-10, with 0 being the lowest satisfaction and 10 being the highest satisfaction.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Hours to Discharge</measure>
    <time_frame>Baseline to discharge (approximately 90 hrs)</time_frame>
    <description>Mean hours to discharge, from the time of admittance to the time of discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Pain Scores in PACU</measure>
    <time_frame>Immediately post operatively, not more than 4 hours after pacu admittance</time_frame>
    <description>The Mean Pain Score (VAS) at no more than 4 hours after the Anesthesia Record Stop Time.
The Visual Analog Scale is a standard numerical pain score reported by the patient, from 0-10, where 0=no pain, and 10=worst pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Pain Scores at 24 Hours</measure>
    <time_frame>From the Anesthesia Record stop time to 24 hours after Anesthesia Record stop time</time_frame>
    <description>Visual Analog Scale (VAS) score at 24 hours from the time of Anesthesia Record Stop Time.
The Visual Analog Scale is a standard numerical pain score reported by the patient, from 0-10, where 0=no pain, and 10=worst pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Pain Scores 48 Hours Postoperatively</measure>
    <time_frame>From the Anesthesia Record Stop Time to 48 hours from the Anesthesia Record Stop Time</time_frame>
    <description>Visual Analog Scale (VAS) score at 48 hours from the time of Anesthesia Record Stop Time.
The Visual Analog Scale is a standard numerical pain score reported by the patient, from 0-10, where 0=no pain, and 10=worst pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Opioid Consumption as Measured in Oral Morphine Milligram Equivalents</measure>
    <time_frame>Post operatively through 4 hours</time_frame>
    <description>Mean opioid consumption as measured immediately post operatively from Anesthesia Record Stop Time to 4 hours after Anesthesia Record Stop Time in Oral Morphine Milligram Equivalents</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Opioid Consumption as Measured in Oral Morphine Milligram Equivalents</measure>
    <time_frame>From immediately post operatively through 24 hours</time_frame>
    <description>Mean opioid consumption as calculated from the time of Anesthesia Record Stop Time to 24 hours after Anesthesia Record Stop Time in Oral Morphine Equivalents</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Opioid Consumption as Measured in Oral Morphine Equivalents</measure>
    <time_frame>From immediately post operatively through 48 hours</time_frame>
    <description>Mean opioid consumption as calculated from Anesthesia Record Stop Time to 48 hours after Anesthesia Record Stop Time in Oral Morphine Milligram Equivalents</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">94</enrollment>
  <condition>Arthropathy of Knee</condition>
  <arm_group>
    <arm_group_label>Adductor Canal Nerve Block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will be randomized using block randomization.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Femoral Nerve Block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will be randomized using block randomization.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Adductor Canal Nerve Block</intervention_name>
    <description>Adductor Canal never technique</description>
    <arm_group_label>Adductor Canal Nerve Block</arm_group_label>
    <other_name>ropivacaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Femoral Nerve Block</intervention_name>
    <description>Traditional technique</description>
    <arm_group_label>Femoral Nerve Block</arm_group_label>
    <other_name>ropivacaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient undergoing total knee arthroplasty with regional anesthesia planned for
             postoperative analgesia.

          -  Adult, 19 years of age or older

          -  Patient classified as American Society of Anesthesiology (ASA) class I, II, or III

        Exclusion Criteria:

          -  Any subject not classified as an ASA I, II, or III

          -  Allergy/intolerance to local anesthetic

          -  Pre-existing neurologic or anatomic deficit in lower extremity on the side of the
             surgical site

          -  Coexisting coagulopathy such as hemophilia or von Willebrand disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Promil Kukreja, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UAB Department of Anesthesiology and Perioperative Medicine</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35249</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>April 14, 2017</study_first_submitted>
  <study_first_submitted_qc>April 25, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 28, 2017</study_first_posted>
  <results_first_submitted>October 2, 2018</results_first_submitted>
  <results_first_submitted_qc>January 14, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">January 16, 2019</results_first_posted>
  <last_update_submitted>January 14, 2019</last_update_submitted>
  <last_update_submitted_qc>January 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alabama at Birmingham</investigator_affiliation>
    <investigator_full_name>Promil Kukreja</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Adductor Canal Block</keyword>
  <keyword>Femoral Canal Block</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Joint Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 24, 2014</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/81/NCT03133481/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Adductor Canal Nerve Block</title>
          <description>Participants will be randomized using block randomization.
Adductor Canal Nerve Block: Adductor Canal never technique</description>
        </group>
        <group group_id="P2">
          <title>Femoral Nerve Block</title>
          <description>Participants will be randomized using block randomization.
Femoral Nerve Block: Traditional technique</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="45"/>
                <participants group_id="P2" count="49"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="45"/>
                <participants group_id="P2" count="45"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>FC Catheter fell out post operative day1</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Adductor Canal Nerve Block</title>
          <description>Participants will be randomized using block randomization.
Adductor Canal Nerve Block: Adductor Canal never technique</description>
        </group>
        <group group_id="B2">
          <title>Femoral Nerve Block</title>
          <description>Participants will be randomized using block randomization.
Femoral Nerve Block: Traditional technique</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="45"/>
            <count group_id="B2" value="49"/>
            <count group_id="B3" value="94"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="45"/>
                    <count group_id="B2" value="49"/>
                    <count group_id="B3" value="94"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="49"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="45"/>
                    <count group_id="B2" value="49"/>
                    <count group_id="B3" value="94"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63.4" spread="10.01"/>
                    <measurement group_id="B2" value="65.4" spread="9.28"/>
                    <measurement group_id="B3" value="64.4" spread="9.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="45"/>
                    <count group_id="B2" value="49"/>
                    <count group_id="B3" value="94"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="59"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="45"/>
                    <count group_id="B2" value="49"/>
                    <count group_id="B3" value="94"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45"/>
                    <measurement group_id="B2" value="49"/>
                    <measurement group_id="B3" value="94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Mean Distance Ambulated at 24 Hours Post Operatively</title>
        <description>Distance ambulated in feet from the end of surgery to 24 hours postoperatively</description>
        <time_frame>Baseline up to 24 hours after the Anesthesia Record Stop Time</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Adductor Canal Nerve Block</title>
            <description>Participants will be randomized using block randomization.
Adductor Canal Nerve Block: Adductor Canal never technique</description>
          </group>
          <group group_id="O2">
            <title>Femoral Nerve Block</title>
            <description>Participants will be randomized using block randomization.
Femoral Nerve Block: Traditional technique</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Distance Ambulated at 24 Hours Post Operatively</title>
          <description>Distance ambulated in feet from the end of surgery to 24 hours postoperatively</description>
          <units>feet</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70.2" spread="66.94"/>
                    <measurement group_id="O2" value="48.44" spread="45.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Mean Distance Ambulated at 48 Hours Post Operatively</title>
        <description>Distance ambulated in feet from the end of surgery to 48 hours postoperatively</description>
        <time_frame>From the Anesthesia Record Stop Time to 48 hours after the Anesthesia Record Stop Time</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Adductor Canal Nerve Block</title>
            <description>Participants will be randomized using block randomization.
Adductor Canal Nerve Block: Adductor Canal never technique</description>
          </group>
          <group group_id="O2">
            <title>Femoral Nerve Block</title>
            <description>Participants will be randomized using block randomization.
Femoral Nerve Block: Traditional technique</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Distance Ambulated at 48 Hours Post Operatively</title>
          <description>Distance ambulated in feet from the end of surgery to 48 hours postoperatively</description>
          <units>feet</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="129.02" spread="92.33"/>
                    <measurement group_id="O2" value="106.38" spread="83.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Pain Scores Immediately Preoperatively</title>
        <description>Visual Analog Scale (VAS) score immediately preoperatively.
The Visual Analog Scale is a standard numerical pain score reported by the patient, from 0-10, where 0=no pain, and 10=worst pain.</description>
        <time_frame>baseline up to time of anesthesia record start time</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Adductor Canal Nerve Block</title>
            <description>Participants will be randomized using block randomization.
Adductor Canal Nerve Block: Adductor Canal never technique</description>
          </group>
          <group group_id="O2">
            <title>Femoral Nerve Block</title>
            <description>Participants will be randomized using block randomization.
Femoral Nerve Block: Traditional technique</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Pain Scores Immediately Preoperatively</title>
          <description>Visual Analog Scale (VAS) score immediately preoperatively.
The Visual Analog Scale is a standard numerical pain score reported by the patient, from 0-10, where 0=no pain, and 10=worst pain.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.07" spread="3.43"/>
                    <measurement group_id="O2" value="3.38" spread="3.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Opioid Consumption as Measured by Oral Morphine Milligram Equivalents</title>
        <description>Preoperatively, opioid consumption will be measured from baseline to the Anesthesia Record Start Time in Oral Morphine Equivalents</description>
        <time_frame>from baseline to two hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Adductor Canal Nerve Block</title>
            <description>Participants will be randomized using block randomization.
Adductor Canal Nerve Block: Adductor Canal never technique</description>
          </group>
          <group group_id="O2">
            <title>Femoral Nerve Block</title>
            <description>Participants will be randomized using block randomization.
Femoral Nerve Block: Traditional technique</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Opioid Consumption as Measured by Oral Morphine Milligram Equivalents</title>
          <description>Preoperatively, opioid consumption will be measured from baseline to the Anesthesia Record Start Time in Oral Morphine Equivalents</description>
          <units>Oral Morphine Milligram Equivalents</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23" spread="8.52"/>
                    <measurement group_id="O2" value="22.33" spread="8.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Satisfaction at 48 Hours Post Operatively</title>
        <description>Patient satisfaction score, on an analog scale from 0-10, with 0 being the lowest satisfaction and 10 being the highest satisfaction.</description>
        <time_frame>Baseline up to 48 hrs</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Adductor Canal Nerve Block</title>
            <description>Participants will be randomized using block randomization.
Adductor Canal Nerve Block: Adductor Canal never technique</description>
          </group>
          <group group_id="O2">
            <title>Femoral Nerve Block</title>
            <description>Participants will be randomized using block randomization.
Femoral Nerve Block: Traditional technique</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Satisfaction at 48 Hours Post Operatively</title>
          <description>Patient satisfaction score, on an analog scale from 0-10, with 0 being the lowest satisfaction and 10 being the highest satisfaction.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.71" spread="2.16"/>
                    <measurement group_id="O2" value="9.24" spread="1.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Hours to Discharge</title>
        <description>Mean hours to discharge, from the time of admittance to the time of discharge</description>
        <time_frame>Baseline to discharge (approximately 90 hrs)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Adductor Canal Nerve Block</title>
            <description>Participants will be randomized using block randomization.
Adductor Canal Nerve Block: Adductor Canal never technique</description>
          </group>
          <group group_id="O2">
            <title>Femoral Nerve Block</title>
            <description>Participants will be randomized using block randomization.
Femoral Nerve Block: Traditional technique</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Hours to Discharge</title>
          <description>Mean hours to discharge, from the time of admittance to the time of discharge</description>
          <units>hours</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.66" spread="32.24"/>
                    <measurement group_id="O2" value="83.78" spread="14.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Pain Scores in PACU</title>
        <description>The Mean Pain Score (VAS) at no more than 4 hours after the Anesthesia Record Stop Time.
The Visual Analog Scale is a standard numerical pain score reported by the patient, from 0-10, where 0=no pain, and 10=worst pain.</description>
        <time_frame>Immediately post operatively, not more than 4 hours after pacu admittance</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Adductor Canal Nerve Block</title>
            <description>Participants will be randomized using block randomization.
Adductor Canal Nerve Block: Adductor Canal never technique</description>
          </group>
          <group group_id="O2">
            <title>Femoral Nerve Block</title>
            <description>Participants will be randomized using block randomization.
Femoral Nerve Block: Traditional technique</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Pain Scores in PACU</title>
          <description>The Mean Pain Score (VAS) at no more than 4 hours after the Anesthesia Record Stop Time.
The Visual Analog Scale is a standard numerical pain score reported by the patient, from 0-10, where 0=no pain, and 10=worst pain.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.91" spread="3.19"/>
                    <measurement group_id="O2" value="2.98" spread="3.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Pain Scores at 24 Hours</title>
        <description>Visual Analog Scale (VAS) score at 24 hours from the time of Anesthesia Record Stop Time.
The Visual Analog Scale is a standard numerical pain score reported by the patient, from 0-10, where 0=no pain, and 10=worst pain.</description>
        <time_frame>From the Anesthesia Record stop time to 24 hours after Anesthesia Record stop time</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Adductor Canal Nerve Block</title>
            <description>Participants will be randomized using block randomization.
Adductor Canal Nerve Block: Adductor Canal never technique</description>
          </group>
          <group group_id="O2">
            <title>Femoral Nerve Block</title>
            <description>Participants will be randomized using block randomization.
Femoral Nerve Block: Traditional technique</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Pain Scores at 24 Hours</title>
          <description>Visual Analog Scale (VAS) score at 24 hours from the time of Anesthesia Record Stop Time.
The Visual Analog Scale is a standard numerical pain score reported by the patient, from 0-10, where 0=no pain, and 10=worst pain.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.18" spread="2.64"/>
                    <measurement group_id="O2" value="4" spread="2.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Pain Scores 48 Hours Postoperatively</title>
        <description>Visual Analog Scale (VAS) score at 48 hours from the time of Anesthesia Record Stop Time.
The Visual Analog Scale is a standard numerical pain score reported by the patient, from 0-10, where 0=no pain, and 10=worst pain.</description>
        <time_frame>From the Anesthesia Record Stop Time to 48 hours from the Anesthesia Record Stop Time</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Adductor Canal Nerve Block</title>
            <description>Participants will be randomized using block randomization.
Adductor Canal Nerve Block: Adductor Canal never technique</description>
          </group>
          <group group_id="O2">
            <title>Femoral Nerve Block</title>
            <description>Participants will be randomized using block randomization.
Femoral Nerve Block: Traditional technique</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Pain Scores 48 Hours Postoperatively</title>
          <description>Visual Analog Scale (VAS) score at 48 hours from the time of Anesthesia Record Stop Time.
The Visual Analog Scale is a standard numerical pain score reported by the patient, from 0-10, where 0=no pain, and 10=worst pain.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.53" spread="2.37"/>
                    <measurement group_id="O2" value="4.44" spread="2.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Opioid Consumption as Measured in Oral Morphine Milligram Equivalents</title>
        <description>Mean opioid consumption as measured immediately post operatively from Anesthesia Record Stop Time to 4 hours after Anesthesia Record Stop Time in Oral Morphine Milligram Equivalents</description>
        <time_frame>Post operatively through 4 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Adductor Canal Nerve Block</title>
            <description>Participants will be randomized using block randomization.
Adductor Canal Nerve Block: Adductor Canal never technique</description>
          </group>
          <group group_id="O2">
            <title>Femoral Nerve Block</title>
            <description>Participants will be randomized using block randomization.
Femoral Nerve Block: Traditional technique</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Opioid Consumption as Measured in Oral Morphine Milligram Equivalents</title>
          <description>Mean opioid consumption as measured immediately post operatively from Anesthesia Record Stop Time to 4 hours after Anesthesia Record Stop Time in Oral Morphine Milligram Equivalents</description>
          <units>Oral Morphine Milligram Equivalents</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53.92" spread="34.56"/>
                    <measurement group_id="O2" value="50.77" spread="32.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Opioid Consumption as Measured in Oral Morphine Milligram Equivalents</title>
        <description>Mean opioid consumption as calculated from the time of Anesthesia Record Stop Time to 24 hours after Anesthesia Record Stop Time in Oral Morphine Equivalents</description>
        <time_frame>From immediately post operatively through 24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Adductor Canal Nerve Block</title>
            <description>Participants will be randomized using block randomization.
Adductor Canal Nerve Block: Adductor Canal never technique</description>
          </group>
          <group group_id="O2">
            <title>Femoral Nerve Block</title>
            <description>Participants will be randomized using block randomization.
Femoral Nerve Block: Traditional technique</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Opioid Consumption as Measured in Oral Morphine Milligram Equivalents</title>
          <description>Mean opioid consumption as calculated from the time of Anesthesia Record Stop Time to 24 hours after Anesthesia Record Stop Time in Oral Morphine Equivalents</description>
          <units>Oral Morphine Milligram Equivalents</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.54" spread="49.81"/>
                    <measurement group_id="O2" value="68.78" spread="55.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Opioid Consumption as Measured in Oral Morphine Equivalents</title>
        <description>Mean opioid consumption as calculated from Anesthesia Record Stop Time to 48 hours after Anesthesia Record Stop Time in Oral Morphine Milligram Equivalents</description>
        <time_frame>From immediately post operatively through 48 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Adductor Canal Nerve Block</title>
            <description>Participants will be randomized using block randomization.
Adductor Canal Nerve Block: Adductor Canal never technique</description>
          </group>
          <group group_id="O2">
            <title>Femoral Nerve Block</title>
            <description>Participants will be randomized using block randomization.
Femoral Nerve Block: Traditional technique</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Opioid Consumption as Measured in Oral Morphine Equivalents</title>
          <description>Mean opioid consumption as calculated from Anesthesia Record Stop Time to 48 hours after Anesthesia Record Stop Time in Oral Morphine Milligram Equivalents</description>
          <units>Oral Morphine Milligram Equivalents</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.49" spread="32.3"/>
                    <measurement group_id="O2" value="44.47" spread="22.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Adductor Canal Nerve Block</title>
          <description>Participants will be randomized using block randomization.
Adductor Canal Nerve Block: Adductor Canal never technique</description>
        </group>
        <group group_id="E2">
          <title>Femoral Nerve Block</title>
          <description>Participants will be randomized using block randomization.
Femoral Nerve Block: Traditional technique</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Adam Sturdivant</name_or_title>
      <organization>University of Alabama at Birmingham</organization>
      <phone>205-934-4042</phone>
      <email>Adamsturdivant@uabmc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

